Jonathan Kaufman
Directeur Général chez LIPELLA PHARMACEUTICALS INC.
Fortune : 637 284 $ au 30/04/2024
Profil
Jonathan Kaufman is the founder of Lipella Pharmaceuticals, Inc. where he holds the title of Chairman, President, CEO, Secretary & Treasurer starting in 2005.
He was also the founder of MenoGenix, Inc. where he served as the Chief Operations Officer starting in 2010.
Dr. Kaufman is also the founder of Knopp Neurosciences, Inc., Proteopure, Inc., and Knopp Biosciences LLC.
Dr. Kaufman's current job is as a Director at Reaction Biology Corp.Dr. Kaufman's former jobs include being a Director, Chief Science Officer & Senior VP at LaunchCyte LLC, President & Director at Crystalplex Corp., Director at Metritrack, Inc., Director at Immunetrics, Inc., Analyst at Merck & Co., Inc., Chief Financial Officer at Semprus BioSciences Corp., Consultant-Bioinformatics Division at GSK Plc, and Principal at Merck Foundation.
Dr. Kaufman's education includes an undergraduate degree from Carnegie Mellon University, a graduate degree from Brown University, an MBA from The Wharton School of the University of Pennsylvania, and doctorate degrees from Perelman School of Medicine and the University of Pennsylvania Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/05/2024 | 898 849 ( 14,38% ) | 637 284 $ | 30/04/2024 |
Postes actifs de Jonathan Kaufman
| Sociétés | Poste | Début |
|---|---|---|
| LIPELLA PHARMACEUTICALS INC. | Directeur Général | 01/01/2005 |
Reaction Biology Corp.
 Reaction Biology Corp. Miscellaneous Commercial ServicesCommercial Services Reaction Biology Corp. specializes in kinase and epigenetic HTS and profiling services. It offers radiolabeled biochemical assays available for multiple enzyme classes including: Kinase Assays, HMT Assays, and HDAC Assays. Its products include Methyltransferase, IDH proteins, Apoptosis, DNA Demethylation, Apoptosis and NQOs. The company was founded by Scott L. Diamond in 2001 and is headquartered in Malvern, PA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jonathan Kaufman
| Sociétés | Poste | Fin |
|---|---|---|
Knopp Biosciences LLC
 Knopp Biosciences LLC Pharmaceuticals: MajorHealth Technology Knopp Biosciences LLC engages in the operation of a drug discovery and development company. It offers dexpramipexole product, an orally bioavaliable small molecule in development treatment of asthma, eosinophil-associated disorders and amyotrophic lateral sclerosis (ALS) disease. The company was founded by Robert Bowser and Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA. | Fondateur | - |
| Merck Foundation | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
LaunchCyte LLC
 LaunchCyte LLC Investment ManagersFinance LaunchCyte LLC (LaunchCyte) is a venture capital firm founded in 2000 by Tom A.Petzinger and Barbara Bailey Carryer. The firm is headquartered in Pittsburgh, Pennsylvania. | Directeur Technique/Scientifique/R&D | - |
Proteopure, Inc.
 Proteopure, Inc. Medical SpecialtiesHealth Technology Proteopure, Inc. develops and markets sample protein preparation kits. The company was founded on May 3, 2006 and is headquartered in Pittsburgh, PA. | Fondateur | - |
Formation de Jonathan Kaufman
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Perelman School of Medicine | Doctorate Degree |
| University of Pennsylvania Medical Center | Doctorate Degree |
| Carnegie Mellon University | Undergraduate Degree |
| Brown University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| GSK PLC | Health Technology |
| LIPELLA PHARMACEUTICALS INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
Crystalplex Corp.
 Crystalplex Corp. SemiconductorsElectronic Technology Crystalplex Corp. operates a biochemistry and diagnostics laboratory that specializes in nanotechnology for the life sciences industry. Its proprietary technology, SapphireTM QDs provides a stable crystal design, flexible polymer matrix morphology, and meets environmentally responsible yet demanding performance requirements for high-end consumer electronics applications such as liquid crystal display televisions, displays, and high-CRI architectural lighting. The company was founded by Thomas A. Petzinge Jr. in 2004 and is headquartered in Pittsburgh, PA. | Electronic Technology |
Reaction Biology Corp.
Reaction Biology Corp. Miscellaneous Commercial ServicesCommercial Services Reaction Biology Corp. specializes in kinase and epigenetic HTS and profiling services. It offers radiolabeled biochemical assays available for multiple enzyme classes including: Kinase Assays, HMT Assays, and HDAC Assays. Its products include Methyltransferase, IDH proteins, Apoptosis, DNA Demethylation, Apoptosis and NQOs. The company was founded by Scott L. Diamond in 2001 and is headquartered in Malvern, PA. | Commercial Services |
| Merck Foundation | |
Proteopure, Inc.
Proteopure, Inc. Medical SpecialtiesHealth Technology Proteopure, Inc. develops and markets sample protein preparation kits. The company was founded on May 3, 2006 and is headquartered in Pittsburgh, PA. | Health Technology |
LaunchCyte LLC
LaunchCyte LLC Investment ManagersFinance LaunchCyte LLC (LaunchCyte) is a venture capital firm founded in 2000 by Tom A.Petzinger and Barbara Bailey Carryer. The firm is headquartered in Pittsburgh, Pennsylvania. | Finance |
Knopp Neurosciences, Inc.
 Knopp Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Knopp Neurosciences, Inc. operates as a drug discovery and development company. It focused on delivering breakthrough treatments in neurological disorders. It operates through three areas: inflammation discovery platform, mitochondrial discovery platform, and ion channel discovery platform. The company was founded by Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Immunetrics, Inc.
 Immunetrics, Inc. BiotechnologyHealth Technology Immunetrics, Inc. operates as a bio-simulation company. The company was founded by Carson Chow, Timothy R. Billiar, Gilles Clermont, Mitchell P. Fink and Yoram Vodovotz in 2001 and is headquartered in Pittsburgh, PA. | Health Technology |
Semprus BioSciences Corp.
 Semprus BioSciences Corp. Pharmaceuticals: GenericHealth Technology Semprus BioSciences, headquartered in Cambridge, Massachusetts, is a venture-backed biomedical company with a dual mission: to provide complication-free medical devices designed to preserve patients' long-term health and quality-of-life and to contribute to healthcare cost efficiencies. Their innovative, multi-faceted approach to durable surface modifications signifies a breakthrough in medical device technology. Their current focus is to enable the first permanently dual-functional (anti-colonization and anti-thrombogenic) vascular access catheter with a single surface modification. Founded out of the Massachusetts Institute of Technology's Langer Lab, the company has developed the next-generation biofunctional surface platform - which is focused on achieving clinical benefits that far exceed current market offerings containing silver, heparin, and antibiotic coatings. Through covalent chemical bonding of their Semprus Surfaces™, a permanent non-leaching biomaterial modification to the device surface, their technology is expected to vastly improve patient outcomes by preventing serious medical complications, such as infection, blood clots, improper healing, and cell overgrowth. They have assembled a world class product development team - scientists, industry executives and clinical experts - who specialize in reducing such complications at the confluence of the human body and implantable devices. | Health Technology |
Metritrack, Inc.
 Metritrack, Inc. Medical SpecialtiesHealth Technology Metritrack, Inc. operates as a biotechnology company which focuses on advancing the current state of breast cancer care by removing the existing limitations of breast ultrasound. Its product, Breast Volume Navigator G-1000, is designed to precisely and instantly perform automated 3D mapping of breast tissue, regardless of deformation or patient motion; essential for diagnostic and treatment purposes in the age of multi-modality imaging and not available with other systems. The company was founded in 2014 and is headquartered in Hillside, IL. | Health Technology |
MenoGenix, Inc.
 MenoGenix, Inc. BiotechnologyHealth Technology MenoGenix, Inc. operates as a biotechnology company. It focuses on development of drugs for menopause and the menopause diseases. The company was founded by Debra M. Duke and Jonathan Kaufman in 2010 and is headquartered in Aurora, CO. | Health Technology |
Knopp Biosciences LLC
Knopp Biosciences LLC Pharmaceuticals: MajorHealth Technology Knopp Biosciences LLC engages in the operation of a drug discovery and development company. It offers dexpramipexole product, an orally bioavaliable small molecule in development treatment of asthma, eosinophil-associated disorders and amyotrophic lateral sclerosis (ALS) disease. The company was founded by Robert Bowser and Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |